In terms of wound regeneration, it is important to note that the administration of EGFR inhibitors (which block EGF as well as TGF-α signaling) for cancer treatment causes adverse cutaneous side effects, and in some cases interferes with wound healing in humans [68], [69]. The gene discussed is EGF; the disease is cancer.